AMBER PHELPS: Open Payments
NPI 1639760382 · ELDERSBURG, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,590 in 82 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $706 · 2025 $1,590
Food & beverage: $1,590
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $201 |
| Lilly USA, LLC | 10 | $185 |
| Lundbeck LLC | 9 | $173 |
| PFIZER INC. | 8 | $161 |
| Bausch Health US, LLC | 8 | $147 |
| Corium, LLC | 5 | $95 |
| ABBVIE INC. | 4 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $59 |
| Axsome Therapeutics, Inc. | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
Products named: REXULTI, MOUNJARO, APLENZIN, Wegovy, NURTEC ODT, JARDIANCE, Azstarys, VRAYLAR.
Industry payments across MD — which companies pay providers there.
